[go: up one dir, main page]

Godara, 2013 - Google Patents

The Washington manual of medical therapeutics

Godara, 2013

View PDF
Document ID
2360352963211216555
Author
Godara H
Publication year

External Links

Snippet

For the past 65 years, The Washington Manual® of Medical Therapeutics, now in its Thirty- Fourth Edition, has been one of the best-selling medical texts in the world. It builds upon that proud tradition--with even more of the current information you need, and delivered in a time …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Similar Documents

Publication Publication Date Title
Godara The Washington manual of medical therapeutics
Crees et al. The Washington Manual of Medical Therapeutics Paperback
US11717504B2 (en) Methods of reducing the risk of cardiovascular events in a subject
Benetos et al. Polypharmacy in the aging patient: management of hypertension in octogenarians
Black et al. Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial
Redfield et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial
Bhat et al. The Washington manual of medical therapeutics
BR112021002884A2 (en) methods to reduce the need for peripheral arterial revascularization in a statin-treated subject
Dabi et al. Reversal strategies for intracranial hemorrhage related to direct oral anticoagulant medications
Ellis et al. Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: a retrospective population-based cohort study
Skelley et al. Betrixaban (Bevyxxa): A direct-acting oral anticoagulant factor Xa inhibitor
Kario et al. Rationale and design for the Asia BP@ Home study on home blood pressure control status in 12 Asian countries and regions
Fernando et al. An open-label, non-inferiority randomized controlled trial of lidocAine Versus Opioids In MyocarDial Infarction study (AVOID-2 study) methods paper
Becerra et al. Decreased rivaroxaban levels in a patient with cerebral vein thrombosis receiving phenytoin
Mistry et al. COMMUNICATION ERROR DURING POST-OPERATIVE PATIENT HAND OFF IN THE PEDIATRIC INTENSIVE CARE UNIT.: 47
EP2585161A1 (en) Medical device for self-administration of patients with acute coronary events
Waldfahrer Management of patients with risk factors
Halpern et al. Perioperative risk assessment in the surgical care of geriatric patients
Qureshi et al. Breaking boundaries: exploring recent advances in anticoagulation and thrombosis management: a comprehensive review
Brady et al. High-Acuity Postoperative and Inpatient Issues
Maumus et al. Hospital Systems Management
Juffermans et al. Leila Atmowihardjo1, Job R. Schippers2, Imke H. Bartelink3, Pierre M. Bet3, Nienke van Rein3, Keith Purdy4, David Cavalla4, Valérie Comberiati5, Andrew McElroy4, Sue D. Snape4, Harm Jan Bogaard2, Leo Heunks6
Pickard et al. Oxford Case Histories Palliative Medicine
Floyd et al. Warfarin Induced Generalized Dermatitis–A Case Study
Bobronnikova et al. Clinical pharmacology: Self–study guide for 5 year English medium students